Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-01-04

Clinical Trial Update: The Platelet-Rich Plasma in the Therapy of Temporomandibular Disorders [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/Phase 3 clinical trial evaluating platelet-rich plasma (PRP) for temporomandibular disorders.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Platelet-rich plasma (platelet-rich plasma)

Snippet

Sponsor: Medical University of Silesia | Conditions: PRP, Temporomandibular Disorder | Phase 2, Phase 3 | Status: COMPLETED